Somatom X.Cite
Payments companies reported to CMS as associated with Somatom X.Cite. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Somatom X.Cite, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Somatom X.Cite
These are the largest totals companies reported as associated with Somatom X.Cite. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Jabour | Clive, IA | Diagnostic Radiology | $5,796.76 |
| Jerry Gibbs | Houston, TX | Vascular & Interventional Radiology | $903.23 |
| Aalpen Patel | Danville, PA | Vascular & Interventional Radiology | $799.10 |
| Matthew Galfione | Houston, TX | Vascular & Interventional Radiology | $698.65 |
| Jedidiah Almond | Newnan, GA | Diagnostic Radiology | $565.50 |
| Ross Christensen | La Jolla, CA | Diagnostic Radiology | $524.32 |
| Albert Parlade | Weston, FL | Diagnostic Radiology | $522.56 |
| Nikunj Patel | La Jolla, CA | Diagnostic Radiology | $511.52 |
| Adrian Wong | Houston, TX | Vascular & Interventional Radiology | $466.84 |
| Jacobo Kirsch | Weston, FL | Diagnostic Radiology | $463.45 |
Prescribed Somatom X.Cite?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.